Measurement and prediction of medication compliance in problem drinkers

Alcoholism: Clinical and Experimental Research

Volumn 27, Issue 8, 2003, Pages 1286-1292

  Feinn, Richard ^a   Tennen, Howard ^a   Cramer, Joyce ^b   Kranzler, Henry R ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Compliance; Daily Reports; MEMS; Pharmacotherapy

Indexed keywords

NALTREXOL; PLACEBO;

ABSTINENCE; ADULT; ALCOHOLISM; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTRONICS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MONITOR; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; TABLET;

ADULT; ALCOHOL DRINKING; FEMALE; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; NALTREXONE; PATIENT COMPLIANCE; PREDICTIVE VALUE OF TESTS; STATISTICS, NONPARAMETRIC;

EID: 0042664069     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ALC.0000080670.59386.6E     Document Type: Article

References (27)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders. 4th ed. American Psychiatric Association, Washington, DC.
2. Armeli S, Tennen H, Affleck G, Kranzler H (2000) Does affect mediate the association between daily events and alcohol use? J Stud Alcohol 61:862-871.
3. Bachmann L, Stephens J, Richey C, Hook E III (1999) Measured versus self-reported compliance with doxycycline therapy for chlamydia-associated syndromes: high therapeutic success rates despite poor compliance. Sex Transm Dis 26:272-278.
4. Boaventura I, Coehlo R, Rocha-Goncalves F (1994) Compliance to therapy - its importance in research and clinical practice. Rev Port Cardiol 13:677-683.
5. Burney K, Krishnan K, Ruffin M, Zhang D, Brenner D (1996) Adherence to single daily dose of aspirin in a chemoprevention trial. An evaluation of self-report and microelectronic monitoring. Arch Fam Med 5:297-300.
6. Chick J, Anton R, Checinski K, Croop R, Drummond DC, Farmer R, Labriola D, Marshall J, Moncrieff J, Morgan MY, Peters T, Ritson B (2000) A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol Alcohol 35:587-593.
7. Cox W, Blount J, Crowe P, Singh S (1996) Diabetic patient's alcohol use and quality of life: relationships with prescribed treatment compliance among older males. Alcohol Clin Exp Res 20:327-331.
8. Cramer JA, Rosenheck R (1999) Enhancing medication compliance for people with serious mental illness. J Nerv Ment Dis 187:53-55.
9. Del Boca FK, Kranzler HR, Brown J, Korner P (1996) Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer. Alcohol Clin Exp Res 20:1412-1417.
10. Diaz E, Levine H, Sullivan M, Sernyak M, Hawkins K, Cramer J, Woods S (2001) Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia. J Psychiatry Neurosci 26:325-329.
11. Fawcett J, Clark D, Aagesen C, Pisani V, Tilkin J, Sellers D, McGuire M, Gibbons R (1987) A double-blind, placebo-controlled trial of lithium carbonate therapy for alcoholism. Arch Gen Psychiatry 44:248-256.
12. Fuller RK, Branchey L, Brightwell DR, Derman RM, Emrick CD, Iber FL, James KE, Lacoursiere RB, Lee KK, Lowenstam I, Maany I, Neiderhiser D, Nocks JJ, Shaw S (1986) Disulfiram treatment of alcoholism: a Veteran's Administration Cooperative Study. JAMA 256:1449-1455.
13. George C, Peveler R, Heiliger S, Thompson C (2000) Compliance with tricyclic antidepressants: the value of four different methods of assessment. Br J Clin Pharmacol 50:166-171.
14. Kranzler HR, Armeli S, Tennen H, Blomqvist O, Oncken C, Petry N, Feinn R (2003) Targeted naltrexone for early problem drinkers. J Clin Psychopharmacol 23:294-304.
15. Miller WR, Tonigan JS, Longabaugh R (1995) The Drinker Inventory of Consequences (DrInC): An Instrument for Assessing Adverse Consequences of Alcohol Abuse. NIAAA Project MATCH Monograph Series Vol. 4. NIH Publication No. 95-3911. Washington, DC: U.S. Government Printing Office.
16. Namkoong K, Farren C, O'Connor P, O'Malley S (1999) Measurement of compliance with naltrexone in the treatment of alcohol dependence: research and clinical implications. J Clin Psychiatry 60:449-453.
17. Olivieri NF, Matsui D, Hermann C, Koren G (1991) Compliance assessed by the Medication Event Monitoring System. Arch Dis Child 66:1399-1402.
18. Paes A, Bakker A, Soe-Agnie C (1998) Measurement of patient compliance. Pharm World Sci 20:73-77.
19. Pullar T, Kumar S, Tindall H, Feely M (1989) Time to stop counting the tablets? Clin Pharmacol Ther 46:163-168.
20. Reid M, Hubbell C, Douglass A, Boedeker K, Reid L (2001) Research with rats germane to medication for alcoholism: consequences of noncompliance. Alcohol 24:169-177.
21. Roth HP, Caron HS, Hsi BP (1970) Measuring intake of a prescribed medication: a bottle count and a tracer technique compared. Clin Pharmacol Ther 11:228-237.
22. Rudd P, Byyny RL, Zachary V, LoVerde ME, Titus C, Mitchell WD, Marshall G (1989) The natural history of medication compliance in a drug trial: limitations of pill counts. Clin Pharmacol Ther 46:169-176.
23. Spriet A, Simon P (1985) Methodology of Clinical Drug Trials (Edelstein R, Weintraub W trans). Karger, Basel, Switzerland.
24. Straka R, Fish J, Benson S, Suh J (1997) Patient self-reporting of compliance does not correspond with electronic monitoring: an evaluation using isosorbide dinitrate as a model drug. Pharmacotherapy 17:126-132.
25. Suen H (1990) Principles of Test Theories. Lawrence Erlbaum, Hillsdale, NJ.
26. Volpicelli J, Rhines K, Rhines J, Volpicelli L, Alterman A, O'Brien C (1997) Naltrexone and alcohol dependence. Role of subject compliance. Arch Gen Psychiatry 54:737-742.
27. Young LM, Haakenson CM, Lee KK, van Eeckout, JP (1984) Riboflavin use as a drug marker in Veterans Administration Cooperative Studies. Control Clin Trials 5:497-504.